<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03322410</url>
  </required_header>
  <id_info>
    <org_study_id>PA17003</org_study_id>
    <nct_id>NCT03322410</nct_id>
  </id_info>
  <brief_title>Hydratation Status at Initiation of Peritoneal Dialysis: Study of the Role of Peritoneal Permeability</brief_title>
  <official_title>Hydratation Status at Initiation of Peritoneal Dialysis: Study of the Role of Peritoneal Permeability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bioimpedance is recently known to be a reliable, reproducible and validated technic allowing
      determination of hydratation status in patients with chronic kidney disease treated with
      peritoneal dialysis (PD). Overhydratation attested by bioimpedance is strongly associated
      with cardio-vascular morbidity and mortality in patients with PD. Overhydratation might
      concern more than half of patients at PD initiation, though the underlying mechanism remains
      unknown.

      High peritoneal permeability (HPP) might concern about a third of patients starting a PD,
      although only a few datas are published on this condition. HPP at initiation of PD is
      associated with a decrease in both technical and patient survival and might be responsible of
      ultrafiltration failure. The underlying mechanisms of HPP at initiation of PD also remains
      unknown.

      To our knowledge, the correlation between hydratation status and peritoneal permeability at
      initiation of peritoneal dialysis remains unknown. Moreover, there is no datas concerning the
      cinetic evolution of peritoneal permeability; demographic or biologic factors associated with
      HPP in days and months following PD start.

      The aim of the present study is to correlate hydratation status (attested by bioimpedance)
      and peritoneal permeability at early start of peritoneal dialysis. Thus, we investigated
      early cinetic of peritoneal permeability at different time point during the first year of
      peritoneal dialysis and we analyzed the demographical and biological factors associated with
      HPP and overhydratation during this period.

      This study is a prospective, multicentric cohort study. Fourty patients recruited in a two
      years' period in five centers of nephrology will be included. Hydratation status will be
      determined with Fluid Overload measurement by bioimpedance technic thanks to BCM system
      (Fresenius Medical Care速). Peritoneal permeability will be determined by modified Peritoneal
      Equilibration Test with complete drainage at sixty minutes. Datas will prospectively be
      collected, including: weight, blood pressure, diuretic posology, diuresis, PD modality,
      dialysate prescribed.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hydratation status</measure>
    <time_frame>Day 7</time_frame>
    <description>Fluid overload (FO) measured with BMC bioimpedance system (Fresenius medical care速)
FO &lt; 10th percentile = extracellular dehydration
10th percentile &lt; FO &lt; 90th percentile = extracellular normohydration
FO &gt; 90th percentile = extracellular hyperhydration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peritoneal permeability</measure>
    <time_frame>Day 7</time_frame>
    <description>Peritoneal permeability status determined by modified Peritoneal Equilibration test with complete drainage at 60 minutes as described for Twardowsky
&quot; High &quot;: D/P creatinine&gt;0,8; D/D0 glucose&lt;0,25
&quot; High average &quot;: 0,65&lt; D/P creatinine &lt;0,8; 0,25&lt; D/D0 glucose &lt;0,38
&quot; Low average &quot;: 0,5&lt; D/P creatinine &lt;0,65; 0,39&lt; D/D0 glucose &lt; 0,48
&quot; Low &quot; : D/P creatinine&lt;0,5 ; D/D0 glucose&gt;0,49.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hydratation status</measure>
    <time_frame>Day 45</time_frame>
    <description>Fluid overload (FO) measured with BMC bioimpedance system (Fresenius medical care速)
FO &lt; 10th percentile = extracellular dehydration
10th percentile &lt; FO &lt; 90th percentile = extracellular normohydration
FO &gt; 90th percentile = extracellular hyperhydration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peritoneal permeability</measure>
    <time_frame>Day 45</time_frame>
    <description>Peritoneal permeability status determined by modified Peritoneal Equilibration test with complete drainage at 60 minutes as described for Twardowsky
&quot; High &quot;: D/P creatinine&gt;0,8; D/D0 glucose&lt;0,25
&quot; High average &quot;: 0,65&lt; D/P creatinine &lt;0,8; 0,25&lt; D/D0 glucose &lt;0,38
&quot; Low average &quot;: 0,5&lt; D/P creatinine &lt;0,65; 0,39&lt; D/D0 glucose &lt; 0,48
&quot; Low &quot; : D/P creatinine&lt;0,5 ; D/D0 glucose&gt;0,49.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hydratation status</measure>
    <time_frame>Day 365</time_frame>
    <description>Fluid overload (FO) measured with BMC bioimpedance system (Fresenius medical care速)
FO &lt; 10th percentile = extracellular dehydration
10th percentile &lt; FO &lt; 90th percentile = extracellular normohydration
FO &gt; 90th percentile = extracellular hyperhydration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peritoneal permeability</measure>
    <time_frame>Day 365</time_frame>
    <description>Peritoneal permeability status determined by modified Peritoneal Equilibration test with complete drainage at 60 minutes as described for Twardowsky
&quot; High &quot;: D/P creatinine&gt;0,8; D/D0 glucose&lt;0,25
&quot; High average &quot;: 0,65&lt; D/P creatinine &lt;0,8; 0,25&lt; D/D0 glucose &lt;0,38
&quot; Low average &quot;: 0,5&lt; D/P creatinine &lt;0,65; 0,39&lt; D/D0 glucose &lt; 0,48
&quot; Low &quot; : D/P creatinine&lt;0,5 ; D/D0 glucose&gt;0,49.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Fluid Overload</condition>
  <condition>Peritoneal Hyperpermeability</condition>
  <condition>Peritoneal Dialysis</condition>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>modified Peritoneal Equilibration test</intervention_name>
    <description>Peritoneal permeability status determined by modified Peritoneal Equilibration test with complete drainage at 60 minutes as described for Twardowsky
&quot; High &quot;: D/P creatinine&gt;0,8; D/D0 glucose&lt;0,25
&quot; High average &quot;: 0,65&lt; D/P creatinine &lt;0,8; 0,25&lt; D/D0 glucose &lt;0,38
&quot; Low average &quot;: 0,5&lt; D/P creatinine &lt;0,65; 0,39&lt; D/D0 glucose &lt; 0,48
&quot; Low &quot; : D/P creatinine&lt;0,5 ; D/D0 glucose&gt;0,49.</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  End stage chronic kidney disease

          -  Ambulatory

          -  Starting a peritoneal dialysis in one of the participant centers

          -  Accepting the study protocol

          -  Age &gt; 18yo

        Exclusion criteria:

          -  Age &lt;18yo

          -  Protected by the law
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fatouma TOURE</last_name>
    <phone>0326787638</phone>
    <phone_ext>+33</phone_ext>
    <email>ftoure@chu-reims.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincent DUPONT</last_name>
    <email>vdupont@vhu-reims.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fatouma TOURE</last_name>
      <email>ftoure@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2017</study_first_submitted>
  <study_first_submitted_qc>October 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2017</study_first_posted>
  <last_update_submitted>October 23, 2017</last_update_submitted>
  <last_update_submitted_qc>October 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fluid overload</keyword>
  <keyword>Hydratation statud</keyword>
  <keyword>Peritoneal hypepermeability</keyword>
  <keyword>Peritoneal dialysis</keyword>
  <keyword>Impedancemetry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

